Cargando…
A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
Human epidermal growth factor receptor 2 (HER2) testing has great value for cancer diagnosis, prognosis and treatment selection. However, the clinical utility of HER2 is frequently tempered by the uncertainty regarding the accuracy of the methods currently available to assess HER2. The development o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162480/ https://www.ncbi.nlm.nih.gov/pubmed/34094372 http://dx.doi.org/10.1039/d0sc04481d |
_version_ | 1783700722115674112 |
---|---|
author | Liu, Liang Kuang, Yuqiong Wang, Zhongcheng Chen, Yun |
author_facet | Liu, Liang Kuang, Yuqiong Wang, Zhongcheng Chen, Yun |
author_sort | Liu, Liang |
collection | PubMed |
description | Human epidermal growth factor receptor 2 (HER2) testing has great value for cancer diagnosis, prognosis and treatment selection. However, the clinical utility of HER2 is frequently tempered by the uncertainty regarding the accuracy of the methods currently available to assess HER2. The development of novel methods for accurate HER2 testing is in great demand. Considering the visualization features of in situ imaging and the quantitative capability of mass spectrometry, integration of the two components into a molecular mapping approach has attracted increasing interest. In this work, we reported an integrated chemical mapping approach using a photocleavable peptide-tagged mass probe for HER2 detection. The probe consists of four functional domains, including the recognition unit of an aptamer to catch HER2, a fluorescent dye moiety (FITC) for fluorescence imaging, a reporter peptide for mass spectrometric quantification, and a photocleavable linker for peptide release. After characterization of this novel probe (e.g., conjugation efficiency, binding affinity and specificity, and photolysis release efficiency), the probe binding and photolysis release conditions were optimized. Then, fluorescence images were collected, and the released reporter peptide after photolysis was quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). A limit of quantification (LOQ) of 25 pM was obtained, which very well meets the requirements for clinical laboratory testing. Finally, the developed assay was applied for HER2 testing in four breast cancer cell lines and 42 pairs of human breast primary tumors and adjacent normal tissue samples. Overall, this integrated approach based on a photocleavable peptide-tagged mass probe can provide chemical mapping including both quantitative and visual information of HER2 reliably and consistently, and may pave the way for clinical applications in a more accurate manner. |
format | Online Article Text |
id | pubmed-8162480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-81624802021-06-04 A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells Liu, Liang Kuang, Yuqiong Wang, Zhongcheng Chen, Yun Chem Sci Chemistry Human epidermal growth factor receptor 2 (HER2) testing has great value for cancer diagnosis, prognosis and treatment selection. However, the clinical utility of HER2 is frequently tempered by the uncertainty regarding the accuracy of the methods currently available to assess HER2. The development of novel methods for accurate HER2 testing is in great demand. Considering the visualization features of in situ imaging and the quantitative capability of mass spectrometry, integration of the two components into a molecular mapping approach has attracted increasing interest. In this work, we reported an integrated chemical mapping approach using a photocleavable peptide-tagged mass probe for HER2 detection. The probe consists of four functional domains, including the recognition unit of an aptamer to catch HER2, a fluorescent dye moiety (FITC) for fluorescence imaging, a reporter peptide for mass spectrometric quantification, and a photocleavable linker for peptide release. After characterization of this novel probe (e.g., conjugation efficiency, binding affinity and specificity, and photolysis release efficiency), the probe binding and photolysis release conditions were optimized. Then, fluorescence images were collected, and the released reporter peptide after photolysis was quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). A limit of quantification (LOQ) of 25 pM was obtained, which very well meets the requirements for clinical laboratory testing. Finally, the developed assay was applied for HER2 testing in four breast cancer cell lines and 42 pairs of human breast primary tumors and adjacent normal tissue samples. Overall, this integrated approach based on a photocleavable peptide-tagged mass probe can provide chemical mapping including both quantitative and visual information of HER2 reliably and consistently, and may pave the way for clinical applications in a more accurate manner. The Royal Society of Chemistry 2020-09-30 /pmc/articles/PMC8162480/ /pubmed/34094372 http://dx.doi.org/10.1039/d0sc04481d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Liu, Liang Kuang, Yuqiong Wang, Zhongcheng Chen, Yun A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells |
title | A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells |
title_full | A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells |
title_fullStr | A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells |
title_full_unstemmed | A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells |
title_short | A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells |
title_sort | photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (her2) in human cancer cells |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162480/ https://www.ncbi.nlm.nih.gov/pubmed/34094372 http://dx.doi.org/10.1039/d0sc04481d |
work_keys_str_mv | AT liuliang aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT kuangyuqiong aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT wangzhongcheng aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT chenyun aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT liuliang photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT kuangyuqiong photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT wangzhongcheng photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells AT chenyun photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells |